CVS Health Corporation CVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.76% | 7.37% | 7.66% | 7.87% | 6.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.76% | 7.37% | 7.66% | 7.87% | 6.66% |
| Cost of Revenue | 6.30% | 6.95% | 7.86% | 7.87% | 7.22% |
| Gross Profit | 9.72% | 10.11% | 6.44% | 7.88% | 3.13% |
| SG&A Expenses | 5.82% | 5.63% | 4.26% | 4.56% | 2.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.25% | 6.80% | 7.45% | 7.49% | 6.70% |
| Operating Income | 25.89% | 30.17% | 16.19% | 24.94% | 4.86% |
| Income Before Tax | 316.71% | -10.90% | -51.89% | -65.26% | -56.77% |
| Income Tax Expenses | -56.77% | -55.03% | -71.46% | -73.88% | 44.44% |
| Earnings from Continuing Operations | 2,480.84% | 8.82% | -44.64% | -62.32% | -91.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -121.95% | -88.10% | -19.44% | 42.86% | 583.33% |
| Net Income | 2,253.30% | 7.92% | -44.47% | -61.68% | -90.65% |
| EBIT | 25.89% | 30.17% | 16.19% | 24.94% | 4.86% |
| EBITDA | 17.22% | 19.37% | 10.50% | 15.92% | 3.45% |
| EPS Basic | 2,114.64% | 6.51% | -45.09% | -61.77% | -90.11% |
| Normalized Basic EPS | 26.39% | 31.53% | 16.31% | 25.97% | 12.87% |
| EPS Diluted | 2,141.91% | 5.53% | -45.80% | -62.25% | -90.29% |
| Normalized Diluted EPS | 25.89% | 31.23% | 16.14% | 25.98% | 13.01% |
| Average Basic Shares Outstanding | 0.97% | 0.91% | 0.85% | 0.64% | -0.16% |
| Average Diluted Shares Outstanding | 1.38% | 1.15% | 1.03% | 0.67% | -0.28% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 2.31% |
| Payout Ratio | -0.96% | -0.06% | 0.82% | 1.63% | 9.94% |